Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126130891 | 12613089 | 1 | I | 20160505 | 20160802 | 20160802 | EXP | NO-ALEMBIC PHARMACUETICALS LIMITED-2016SCAL000592 | ALEMBIC | FROST J, LOKKEN TN, HELLAND A, NORDRUM IS, SLORDAL L. POST-MORTEM LEVELS AND TISSUE DISTRIBUTION OF CODEINE, CODEINE-6-GLUCURONIDE, NORCODEINE, MORPHINE AND MORPHINE GLUCURONIDES IN A SERIES OF CODEINE-RELATED DEATHS. FORENSIC SCIENCE INTERNATIONAL. 2016;262:128-137 | 0.00 | Y | 0.00000 | 20160802 | MD | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126130891 | 12613089 | 1 | PS | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | 78932 | |||||||||||
| 126130891 | 12613089 | 2 | SS | PREGABALIN. | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 3 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 4 | SS | CODEINE /00012602/ | CODEINE PHOSPHATE | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 5 | SS | ZOPICLONE | ZOPICLONE | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 6 | SS | DIAZEPAM. | DIAZEPAM | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 7 | SS | OXAZEPAM. | OXAZEPAM | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 8 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | UNK | 0 | |||||||||||
| 126130891 | 12613089 | 9 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126130891 | 12613089 | 1 | Product used for unknown indication |
| 126130891 | 12613089 | 2 | Product used for unknown indication |
| 126130891 | 12613089 | 3 | Product used for unknown indication |
| 126130891 | 12613089 | 4 | Product used for unknown indication |
| 126130891 | 12613089 | 5 | Product used for unknown indication |
| 126130891 | 12613089 | 6 | Product used for unknown indication |
| 126130891 | 12613089 | 7 | Product used for unknown indication |
| 126130891 | 12613089 | 8 | Product used for unknown indication |
| 126130891 | 12613089 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126130891 | 12613089 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126130891 | 12613089 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |